AAAAAA

   
Results: 1-18 |
Results: 18

Authors: Wu, MH Liebowitz, DN Smith, SL Williams, SF Dolan, ME
Citation: Mh. Wu et al., Efficient expression of foreign genes in human CD34(+) hematopoietic precursor cells using electroporation, GENE THER, 8(5), 2001, pp. 384-390

Authors: Laport, GG Fleming, GF Waggoner, S Zimmerman, TM Grinblatt, DL Williams, SF
Citation: Gg. Laport et al., A phase II trial of docetaxel for peripheral blood stem cell mobilization for patients with breast cancer and ovarian cancer, BONE MAR TR, 27(7), 2001, pp. 677-681

Authors: Wu, MH Smith, SL Danet, GH Lin, AM Williams, SF Liebowitz, DN Dolan, ME
Citation: Mh. Wu et al., Optimization of culture conditions to enhance transfection of human CD34(+) cells by electroporation, BONE MAR TR, 27(11), 2001, pp. 1201-1209

Authors: Williams, SF
Citation: Sf. Williams, Squaring the vicious circle, ADM LAW REV, 53(1), 2001, pp. 257-270

Authors: Laport, GG Valone, FH Zimmerman, TM Grinblatt, DL Van Vlasselaer, P Still, BJ Williams, SF
Citation: Gg. Laport et al., Transplantation with low-density autologous PBSC prepared with BDS60 for women with stage II, III and IV breast cancer, CYTOTHERAPY, 2(3), 2000, pp. 179-185

Authors: Zimmerman, TM Lee, WJ Bender, JG Schilling, M Smith, SL Van Epps, DE Williams, SF
Citation: Tm. Zimmerman et al., Clinical impact of ex vivo differentiated myeloid precursors after high-dose chemotherapy and peripheral blood progenitor cell rescue, BONE MAR TR, 26(5), 2000, pp. 505-510

Authors: Brockstein, BE Smiley, C Al-Sadir, J Williams, SF
Citation: Be. Brockstein et al., Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors, BONE MAR TR, 25(8), 2000, pp. 885-894

Authors: Williams, SF Schilsky, RL
Citation: Sf. Williams et Rl. Schilsky, Antineoplastic drugs administered during pregnancy, SEMIN ONCOL, 27(6), 2000, pp. 618-622

Authors: Williams, SF
Citation: Sf. Williams, What is the optimal timing of autologous transplantation for metastatic breast cancer?, CUR CLIN ON, 2000, pp. 191-197

Authors: Shammo, JM Smith, SL Bennett, MV Lee, HW Ostrander, A Ross, AA Williams, SF
Citation: Jm. Shammo et al., Use of a tumor-cell enrichment column for the enhanced detection of minimal residual disease in the BM or apheresis peripheral blood transplant products of breast-cancer patients, CYTOTHERAPY, 1(5), 1999, pp. 367-376

Authors: Hollingsworth, KL Zimmerman, TM Karrison, T Oliver, A Williams, SF
Citation: Kl. Hollingsworth et al., The CD34+cell concentration in peripheral blood predicts CD34+cell yield in the leukapheresis product, CYTOTHERAPY, 1(2), 1999, pp. 141-146

Authors: Zimmerman, TM Michelson, GC Mick, R Grinblatt, DL Williams, SF
Citation: Tm. Zimmerman et al., Timing of platelet recovery is associated with adequacy of leukapheresis product yield after cyclophosphamide and G-CSF in patients with lymphoma, J CLIN APH, 14(1), 1999, pp. 31-34

Authors: Sobecks, RM Le Beau, MM Anastasi, J Williams, SF
Citation: Rm. Sobecks et al., Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation, BONE MAR TR, 23(11), 1999, pp. 1161-1165

Authors: Williams, SF Martin, DP Horowitz, DM Peoples, OP
Citation: Sf. Williams et al., PHA applications: Addressing the price performance issue I. Tissue engineering, INT J BIO M, 25(1-3), 1999, pp. 111-121

Authors: Rowlings, PA Williams, SF Antman, KH Fields, KK Fay, JW Reed, E Pelz, CJ Klein, JP Sobocinski, KA Kennedy, MJ Freytes, CO McCarthy, PL Herzig, RH Stadtmauer, EA Lazarus, HM Pecora, AL Bitran, JD Wolff, SN Gale, RP Armitage, JO Vaughan, WP Spitzer, G Horowitz, MM
Citation: Pa. Rowlings et al., Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer, J AM MED A, 282(14), 1999, pp. 1335-1343

Authors: Shpall, EJ Wheeler, CA Turner, SA Yanovich, S Brown, RA Pecora, AL Shea, TC Mangan, KF Williams, SF LeMaistre, CF Long, GD Jones, R Davis, MW Murphy-Filkins, R Parker, WRL Glaspy, JA
Citation: Ej. Shpall et al., A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients, BLOOD, 93(8), 1999, pp. 2491-2501

Authors: Zimmerman, TM Williams, SF
Citation: Tm. Zimmerman et Sf. Williams, Clinical applications of ex vivo cultured CD34(+) cells and myeloid progenitors, CYTOK CELL, 4(4), 1998, pp. 257-264

Authors: Williams, SF
Citation: Sf. Williams, Restoring context, distorting text: Legislative history and the problem ofage, GEORGE WASH, 66(5-6), 1998, pp. 1366-1369
Risultati: 1-18 |